NCT05850988

Brief Summary

The goal of this study is to observe the effects of different oxygen concentrations during preoxygenation in spontaneous breathing patients with modified lung ultrasound scores before induction of general anesthesia. Preoxygenation is a routine and recommended procedure for patients undergoing general anesthesia. Atelectasis is a common side effect of general anesthesia and usage of high concentration oxygen is a probable cause of it. Using lower oxygen concentrations in preoxygenation may help reducing the atelectasis and it can be assessed by lung ultrasound.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

April 15, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2023

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

December 11, 2023

Status Verified

December 1, 2023

Enrollment Period

1 month

First QC Date

April 6, 2023

Last Update Submit

December 8, 2023

Conditions

Keywords

atelectasispreoxygenationlung ultrasoundgeneral anesthesia

Outcome Measures

Primary Outcomes (1)

  • Change of Modified Lung Ultrasound Scores

    Scores between 0-3 for 12 thorax quadrants and total score will be recorded for each participants before and after a 3 minutes time of preoxygenation to assess change from baseline

    3 minutes

Secondary Outcomes (1)

  • End-Tidal Oxygen levels

    3 minutes

Study Arms (2)

Group Eighty

ACTIVE COMPARATOR

Patients in Group E will receive %80 oxygen for 3 minutes during preoxygenation

Other: %80 Oxygen concentration

Group Hundred

ACTIVE COMPARATOR

Patients in Group H will receive %100 oxygen for 3 minutes during preoxygenation

Other: %100 Oxygen concentration

Interventions

Patients will be administered %80 Oxygen for 3 minutes during preoxygenation.

Also known as: %80 Inspired fraction of oxygen
Group Eighty

Patients will be administered %100 Oxygen for 3 minutes during preoxygenation.

Also known as: %100 Inspired fraction of oxygen
Group Hundred

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists Score I and II
  • Being a candidate to elective surgery under general anesthesia

You may not qualify if:

  • Patients with any pulmonary disease
  • Patients who had pulmonary infection in the past 3 months
  • Patients who had a surgery in the past 3 months
  • Patients who had a multitrauma in the past 3 months
  • Patients who have a Body Mass Index over 30
  • Pregnants
  • Patients who have diaphragma hernia
  • Patients who have gastroesophageal reflux disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, 06710, Turkey (Türkiye)

Location

Related Publications (1)

  • Monastesse A, Girard F, Massicotte N, Chartrand-Lefebvre C, Girard M. Lung Ultrasonography for the Assessment of Perioperative Atelectasis: A Pilot Feasibility Study. Anesth Analg. 2017 Feb;124(2):494-504. doi: 10.1213/ANE.0000000000001603.

    PMID: 27669555BACKGROUND

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Officials

  • Derya Ozkan, Professor MD

    Ozkan D

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor M.D.

Study Record Dates

First Submitted

April 6, 2023

First Posted

May 9, 2023

Study Start

April 15, 2023

Primary Completion

May 20, 2023

Study Completion

June 1, 2023

Last Updated

December 11, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations